EDAP TMS Stock Price

-0.04 (-0.49%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
  Price Change Change Percent Stock Price Last Traded
-0.04 -0.49% 8.07 19:09:10
Open Price Low Price High Price Close Price Prev Close
8.00 7.83 8.20 8.03 8.11
Bid Price Ask Price Spread News
8.07 8.11 0.04 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
737 159,925 $ 8.03 $ 1,283,420 168,476 1.46 - 8.45
Last Trade Time Type Quantity Stock Price Currency
19:09:09 formt 100 $ 8.07 USD

EDAP TMS Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 235.17M 29.14M 29.14M $ 50.40M $ -4.76M 0.06 -55.00
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »


Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical EDAP Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week6.968.456.507.90345,1261.1115.95%
1 Month5.078.454.786.53235,6613.0059.17%
3 Months4.338.453.755.59142,8913.7486.37%
6 Months3.408.453.004.91111,9884.67137.35%
1 Year3.988.451.463.84114,3654.09102.76%
3 Years2.718.451.353.75164,6415.36197.79%
5 Years3.658.451.353.63127,9454.42121.1%

EDAP TMS Description

Edap TMS SAis a holding company operating in two divisions namely, High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS). The HIFU division develops, manufactures and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets two HIFU devices: the Ablatherm, treatment of organ-confined prostate cancer; and the Focal One, for the focal therapy of localized prostate cancer destroying targeted cancer cells only. The UDS division develops, markets, manufactures and services medical devices for the invasive diagnosis or treatment of urological disorders, mainly urinary stones, and other clinical indications. The business of the presence of the firm are sen Asia, France, United States and other regions.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.